Precauciones al indicar antiinflamatorios no esteroideos para controlar el dolor dental en pacientes con COVID-19

Britto Ebert Falcón Guerrero, Guido Sebastián Falcón Pasapera

Texto completo:

PDF Full Text

Palabras clave

biosegurídad; odontología, dental, epidemiología; infectología


Basille D, Plouvier N, Trouve C, Duhaut P, Andrejak C, Jounieaux V. Non-steroidal Anti-inflammatory Drugs may Worsen the Course of Community-Acquired Pneumonia: A Cohort Study. Lung. 2017;195(2):201-208. doi:10.1007/s00408-016-9973-1

Sodhi M, Khosrow-Khavar F, FitzGerald JM, Etminan M. Non-steroidal Anti-inflammatory Drugs and the Risk of Pneumonia Complications: A Systematic Review [published online ahead of print, 2020 Jul 26]. Pharmacotherapy. 2020;10.1002/phar.2451. doi:10.1002/phar.2451. Disponible en:

Russell B, Moss C, Rigg A, Van Hemelrijck M. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?. Ecancermedicalscience. 2020;14:1023. Published 2020 Mar 30. doi:10.3332/ecancer.2020.1023. Disponible en:

FitzGerald GA. Misguided drug advice for COVID-19. Science. 2020;367(6485):1434. doi:10.1126/science.abb8034. Disponible en:

Bruce E, Barlow-Pay F, Short R, Vilches-Moraga A, Angeline Price A, McGovern A, et al. Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19. J Clin Med. 2020;9(8):E2586. Published 2020 Aug 10. doi:10.3390/jcm9082586. Disponible en: